A Phase II Study of Carfilzomib in Relapsed Waldenstrom's Macroglobulinemia (WM) IST-CAR-531
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone; Rituximab
- Indications Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 21 Aug 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov.
- 21 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.